Syncona Partners
Investor profile
Venture capital
Syncona Partners has backed 10 European tech companies across 13 funding rounds between 2014 and 2026, joining rounds totalling €1.0B. Most active in Healthtech. Data as of Nov 2026.
Also recorded as: Syncona Investment Management · Syncona Limited · Syncona Partners LLP · Syncona Partners LLP.
Deals
13
distinct rounds
Companies
10
backed
Active span
2014–2026
13 yrs
Total round €
€1.0B
sum of rounds joined
Deals by year
distinct rounds / yearSyncona Partners — deals by year — interactive chart.
Data table
| Syncona Partners — deals by year | |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Top sectors
by dealsSyncona Partners — top sectors — interactive chart.
Data table
| Syncona Partners — top sectors | |
|---|---|
| Healthtech | 13 |
Stages
by dealsSyncona Partners — stages — interactive chart.
Data table
| Syncona Partners — stages | |
|---|---|
| Series B | 6 |
| Series A | 3 |
| Series C | 3 |
| Other | 1 |
Countries
by dealsSyncona Partners — countries — interactive chart.
Data table
| Syncona Partners — countries | |
|---|---|
| UK | 9 |
| Switzerland | 3 |
| Netherlands | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Forbion2
- GV2
- Janus Henderson Investors2
- Jeito Capital2
- New Science Ventures2
- Northpond Ventures2
- Novo Holdings2
- Oxford Science Enterprises2
- Sanofi Ventures2
- SV Health Investors2
- Wellington Partners2
- 3B Future Health Fund1
- Bain Capital Life Sciences1
- British Business Bank1
- British Patient Capital1
- Cambridge Enterprise1
- Cambridge Innovation Capital1
- Cowen Healthcare Investments1
- EcoR1 Capital1
- EIC Fund1
- Eventide Asset Management1
- Fidelity Management & Research Company LLC1
- GV (Google Ventures)1
- INKEF Capital1
- Jefferson Life Sciences1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| OMass Therapeutics | UK | 2 | €362M |
| Quell Therapeutics | UK | 1 | €138M |
| Anaveon | Switzerland | 2 | €136M |
| Freeline Therapeutics | UK | 1 | €107M |
| Neogene Therapeutics | Netherlands | 1 | €93M |
| iOnctura | Switzerland | 1 | €80M |
| Nightstar | UK | 1 | €39M |
| Azeria Therapeutics | UK | 1 | €36M |
| Mosaic Therapeutics | UK | 1 | €25M |
| Cambridge Epigenetix | UK | 2 | €24M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Freeline Therapeutics | Series C | €107M | 2020-07 |
| Anaveon | Series B | €105M | 2021-12 |
| Neogene Therapeutics | Other | €93M | 2020-09 |
| OMass Therapeutics | Series B | €90M | 2022-04 |
| iOnctura | Series B | €80M | 2024-06 |
| Nightstar | Series C | €39M | 2017-07 |
| Azeria Therapeutics | Series B | €36M | 2019-10 |
| Anaveon | Series A | €31M | 2019-01 |
| Mosaic Therapeutics | Series A | €25M | 2023-04 |